The status of TLR7 in those CD20+ B cells in the pancreatic islets of individuals with type 1 diabetes is currently unknown, but, given that an elevated proportion of infiltrating B cells correlates with earlier diagnosis and more rapidly progressive disease [6], targeting of TLR7 could be of interest therapeutically. The gene discussed is TLR7; the disease is type 1 diabetes mellitus.